ImmunityBio, Inc. — Director's Dealing 2020

Aug 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2020-08-11

Reporting Person: Cohen Cheryl (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-11	Common Stock	S	30000	$9.9595	Disposed	270925	Direct

Footnotes

F1: Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person.

F2: Represents the weighted average share price of an aggregate total of 30,000 shares sold in the price range of $9.91 to $9.99 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.